Incidence of hepatocellular cancer in India: Analysis of population based cancer registry data.

Authors

null

Harish Gopalakrishna

National Institutes of Health, Bethesda, MD

Harish Gopalakrishna , Bin Huang , Aju Mathew

Organizations

National Institutes of Health, Bethesda, MD, University of Kentucky, Markey Cancer Center, Division of Biostatistics, Lexington, KY, Malankara Orthodox Syrian Church Medical College and Hospital, Kolenchery, India

Research Funding

No funding received
None.

Background: Hepatocellular cancer (HCC) is the most common primary liver cancer and the third most common cause of cancer death globally. HCC incidence rate is declining in certain highly prevalent regions, however, continues to rise in many countries where the prevalence is currently low. To understand the trend of HCC incidence in India, we analyzed HCC incidence from various regions in India from 2004 to 2014. Methods: We obtained data on HCC incidence from the Population Based Cancer Registries (PBCR) of the National Cancer Registry Program. This registry includes data from different regions spread across India. We calculated age-standardized incidence rates (to WHO World standard population 2000) for periods of diagnosis (2004-05, 2006-08, 2009-11, and 2012-14). Results: From 2004 to 2014, HCC incidence rates increased relatively by 11%. When compared to data from 2004-2005, HCC incidence rate increased absolutely from 3 per 100,000 persons to 3.3 per 100,000 persons in 2012-2014. From 2004 to 2014, the relative increase in incidence rate was 13.3% in males and 7.4% in females. Conclusions: Rising HCC incidence rate is a cause for concern in India. Globally Nonalcoholic fatty liver disease (NAFLD) is swiftly becoming the most important cause of HCC. The rise in HCC incidence in India could be likely due to the increasing prevalence of NAFLD. Effective strategies are needed to improve surveillance and early diagnosis in patients with high risk of developing hepatocellular cancer. NAFLD preventive strategies must be an urgent public health measure in India.

Overall age-standardized rate for liver cancer (2004-2014) (per 100,000 persons).

Registry/Region2004-20052006-20082009-20112012-2014Trend (% change)
India3.0 (2.8-3.2)2.9 (2.7-3.1)3.1 (3.0-3.3)3.3 (3.1-3.5)↑11%
Barshi1.3 (0.6-2.3)2.8 (1.9-3.9)2.1 (1.3-3.4)2.5 (1.7-3.4)↑95.7%
Bhopal2.0 (1.4-2.8)1.3 (0.9-1.8)1.7 (1.2-2.3)2.3 (1.7-2.9)↑11.4%
Chennai2.1 (1.8-2.4)2.5 (2.2-2.8)3.1 (2.6-3.7)3.5 (3.1-3.9)↑66.0%
Delhi2.3 (2.0-2.5)2.3 (2.1-2.5)2.2 (2.0-2.5)2.7 (2.4-3.0)↑18.0%
Kamrup2.4 (1.6-3.5)3.2 (2.5-4.2)4.2 (3.3-5.2)6.2 (5.2-7.4)↑157.9%
Kolkata1.6 (1.3-2.0)2.0 (1.7-2.3)2.4 (2.1-2.7)2.6 (2.2-3.1)↑61.4%
Mumbai3.8 (3.5-4.2)4.6 (4.3-4.9)4.3 (4.0-4.6)5.7 (5.2-6.2)↑48.0%
Thiruvananthapuram-2.6 (2.2-3.1)3.1 (2.5-3.7)3.2 (2.9-3.6)↑25.2%

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2023 ASCO Annual Meeting

Session Type

Publication Only

Session Title

Publication Only: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Hepatobiliary Cancer - Local-Regional Disease

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr e16233)

DOI

10.1200/JCO.2023.41.16_suppl.e16233

Abstract #

e16233

Abstract Disclosures

Similar Abstracts

First Author: Sri Harsha Tella

First Author: Jeremy Chang

First Author: Jeremy Chang